Wuhu Token Sciences Co., Ltd. (300088.SZ) Bundle
Curious whether Wuhu Token Sciences Co., Ltd. (300088.SZ) is a value play or a cautionary tale? The company posted revenue of CNY 11.06 billion in 2024-a 24.40% surge from CNY 8.89 billion-and TTM revenue of CNY 11.25 billion with quarterly revenue growth of 7.30%, yet faces a modest gross profit margin of 9.38% and a nine‑month net income of CNY 387.02 million (net margin 3.44%) while trading at a trailing PE of 40.41 and a market capitalization of CNY 15.49 billion; dive into revenue drivers, profitability shifts (TTM EPS CNY 0.15, ROE 4.30%), debt structure (debt/equity 33.9%), liquidity blind spots, valuation multiples (P/S 1.32, P/B 1.71, EV/EBITDA 15.52) and the risks and growth avenues that could reshape investor returns.
Wuhu Token Sciences Co., Ltd. (300088.SZ) - Revenue Analysis
Wuhu Token Sciences Co., Ltd. reported notable top-line expansion in recent reporting periods, with mixed momentum into 2025. Key figures and trend metrics below provide a focused view of revenue performance, margin context, valuation vs. sales, and short‑term growth dynamics.
- 2024 full-year revenue: CNY 11.06 billion (up 24.40% vs. CNY 8.89 billion in 2023).
- Nine months ending 30 Sep 2025 revenue: CNY 8.96 billion (up 3.72% YoY vs. CNY 8.64 billion for the same period in 2024).
- Trailing twelve months (TTM) revenue as of 31 Mar 2025: CNY 11.25 billion; quarterly revenue growth: 7.30%.
- Revenue per share (TTM): CNY 4.72; Price-to-Sales (P/S): 1.32.
- Gross profit margin (TTM ending 31 Mar 2025): ~9.38%.
- Market capitalization (as of 3 Nov 2025): CNY 15.49 billion.
| Metric / Period | Value | Notes |
|---|---|---|
| Revenue (2024 FY) | CNY 11.06 billion | Increase of 24.40% vs. 2023 (CNY 8.89B) |
| Revenue (9M 2025: Jan-Sep) | CNY 8.96 billion | Up 3.72% YoY vs. 9M 2024 (CNY 8.64B) |
| TTM Revenue (as of 31 Mar 2025) | CNY 11.25 billion | Quarterly revenue growth: 7.30% |
| Revenue per share (TTM) | CNY 4.72 | Used to compute per-share sales-based valuation |
| Price-to-Sales (P/S) | 1.32 | Market valuation relative to TTM sales |
| Gross profit margin (TTM) | ~9.38% | Share of revenue retained after direct costs |
| Market capitalization (3 Nov 2025) | CNY 15.49 billion | Reflects investor pricing as of the date |
Revenue dynamics show a strong recovery in 2024 followed by slowing YoY growth in the first nine months of 2025, while TTM indicators (31 Mar 2025) reflect continued expansion and a modestly improving quarterly cadence. For background on the company's history, ownership and business model, see: Wuhu Token Sciences Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money
Wuhu Token Sciences Co., Ltd. (300088.SZ) - Profitability Metrics
Wuhu Token Sciences posted net income of CNY 387.02 million for the nine months ended September 30, 2025, delivering a net profit margin of 3.44% and signaling positive bottom-line performance amid a challenging macro backdrop. Operating income on a trailing-12-month (TTM) basis through March 31, 2025, was CNY 361.39 million, showing core business profitability that is largely consistent with reported net margins.- Net income (9M Sep 30, 2025): CNY 387.02 million
- Net profit margin (9M Sep 30, 2025): 3.44%
- Operating income (TTM Mar 31, 2025): CNY 361.39 million
- Operating margin (TTM): 3.17%
- Return on Assets (TTM): 1.42%
- Return on Equity (TTM): 4.30%
- Earnings Per Share (EPS, TTM): CNY 0.15
- Trailing P/E: 40.41
- Quarterly earnings growth YoY: 61.10%
| Metric | Value | Period |
|---|---|---|
| Net Income | CNY 387.02 million | 9 months ended Sep 30, 2025 |
| Net Profit Margin | 3.44% | 9 months ended Sep 30, 2025 |
| Operating Income | CNY 361.39 million | TTM ended Mar 31, 2025 |
| Operating Margin | 3.17% | TTM ended Mar 31, 2025 |
| Return on Assets (ROA) | 1.42% | TTM |
| Return on Equity (ROE) | 4.30% | TTM |
| EPS (TTM) | CNY 0.15 | TTM |
| Trailing P/E | 40.41 | TTM |
| Quarterly Earnings Growth (YoY) | 61.10% | Latest quarter |
- Improvement drivers: strong quarterly earnings growth suggests either revenue acceleration, margin recovery, or favorable one-off items.
- Valuation context: P/E of 40.41 is elevated relative to EPS CNY 0.15 - implies market-priced growth expectations.
- Efficiency focus: low ROA/ROE points to potential benefits from asset utilization or capital structure changes.
Wuhu Token Sciences Co., Ltd. (300088.SZ) - Debt vs. Equity Structure
Wuhu Token Sciences Co., Ltd. shows a conservative capital structure characterized by a moderate debt load relative to equity and a market valuation that reflects its financing mix.
- Debt-to-equity ratio: 33.9% - indicates moderate leverage.
- Enterprise value (EV): CNY 17.42 billion - incorporates market cap and net debt to reflect total operating value.
- Market capitalization: CNY 14.79 billion - implies net debt contributes to EV above market equity value.
- Reported total liabilities and equity as of 2025-03-31: not specified in available data - exact balance-sheet composition unavailable.
The 33.9% debt-to-equity ratio points to a measured reliance on debt financing. With EV (CNY 17.42b) exceeding market cap (CNY 14.79b), the implied net debt portion is material but not excessive, consistent with a balanced capital mix that can support both growth and downside protection.
| Metric | Value | Notes |
|---|---|---|
| Debt-to-Equity Ratio | 33.9% | Moderate leverage |
| Enterprise Value (EV) | CNY 17.42 billion | Includes market cap + net debt |
| Market Capitalization | CNY 14.79 billion | Equity market value as of latest available data |
| Total Liabilities & Equity (2025-03-31) | Not specified | Further disclosure required to detail composition |
Key implications for investors:
- Conservative leverage profile can reduce financial risk during downturns.
- Balanced capital structure provides flexibility for capex, R&D, or strategic M&A.
- Debt service capacity is not directly evidenced - interest coverage and operating cash flow metrics should be reviewed.
For context on the company's broader strategy and values that may influence capital decisions, see: Mission Statement, Vision, & Core Values (2026) of Wuhu Token Sciences Co., Ltd.
Wuhu Token Sciences Co., Ltd. (300088.SZ) Liquidity and Solvency
Available public information for Wuhu Token Sciences Co., Ltd. (300088.SZ) is limited for several core liquidity and solvency metrics. The absence of explicit ratios and cash-flow figures constrains precise assessment of short-term and long-term financial resilience. The following points summarize the specific gaps and the limited signals that can be drawn from the data that is available.
- Current ratio: Not specified in available disclosures; short-term liquidity cannot be quantified.
- Quick ratio: Not specified; immediate liquidity (ex-cash-inventory) is unknown.
- Cash flow from operations: Not provided; ability to generate operating cash to meet obligations is unclear.
- Debt-to-assets ratio: Not disclosed; long-term leverage level is not directly measurable.
- Interest coverage ratio: Not provided; capacity to service interest expense cannot be assessed.
- Working capital: Not specified; operational liquidity and short-term efficiency are indeterminate.
- Solvency position: Based on available high-level information, solvency appears stable, but this is a tentative view requiring fuller data.
| Metric | Reported Value / Status | Implication for Investors |
|---|---|---|
| Current Ratio | Not disclosed | Cannot determine short-term coverage of current liabilities |
| Quick Ratio | Not disclosed | Immediate liquidity assessment unavailable |
| Operating Cash Flow | Not disclosed | Unclear whether operations generate sufficient cash |
| Working Capital | Not specified | Operational liquidity and short-term buffer unknown |
| Debt-to-Assets Ratio | Not disclosed | Leverage and long-term solvency cannot be quantified |
| Interest Coverage Ratio | Not disclosed | Ability to meet interest obligations not assessable |
| Overall Solvency Signal | Appears stable (limited evidence) | Indicative but requires full financial statements for confirmation |
Key practical next steps for investors seeking clarity:
- Request or review the company's full financial statements and cash-flow statements for the latest reporting period.
- Compute current and quick ratios, working capital, debt-to-assets and interest coverage once underlying figures (current assets, inventories, current liabilities, total debt, EBIT, operating cash flow) are available.
- Monitor management commentary and auditor notes for off-balance-sheet items or contingent liabilities that could affect solvency.
Further context and investor-focused details can be found here: Exploring Wuhu Token Sciences Co., Ltd. Investor Profile: Who's Buying and Why?
Wuhu Token Sciences Co., Ltd. (300088.SZ) - Valuation Analysis
Wuhu Token Sciences' market valuation sits in a middle ground: neither deeply discounted nor richly priced. The current multiples reflect moderate investor expectations for earnings growth while pricing in the company's revenue and asset base.
- Trailing PE: 40.41 - indicates historical earnings are modest relative to price, signaling investor willingness to pay a premium for recent profitability.
- Forward PE: 32.89 - implies analysts/market expect earnings to improve over the next 12 months, lowering the PE vs. trailing.
- Price-to-Sales (P/S): 1.32 - a reasonable valuation vs. sales, suggesting revenue is being valued but not exuberantly priced.
- Price-to-Book (P/B): 1.71 - stock trades at a slight premium to book value, reflecting some intangible value or growth expectations beyond net assets.
- EV/Revenue: 1.46 - enterprise value relative to revenue shows overall firm valuation includes leverage and minority interests, aligning with the P/S picture.
- EV/EBITDA: 15.52 - a moderate multiple that suggests investors expect steady cash generation but aren't pricing in aggressive margin expansion.
- Market capitalization (as of 2025-11-03): CNY 15.49 billion - a mid-cap market size indicating meaningful scale and investor attention.
| Metric | Value | Interpretation |
|---|---|---|
| Trailing PE | 40.41 | Premium to historical earnings; growth priced in |
| Forward PE | 32.89 | Expected earnings growth reduces multiple |
| Price-to-Sales (P/S) | 1.32 | Moderate valuation vs. revenue |
| Price-to-Book (P/B) | 1.71 | Slight premium to book value |
| EV/Revenue | 1.46 | Enterprise valuation aligned with P/S |
| EV/EBITDA | 15.52 | Moderate cash-flow multiple |
| Market Cap (2025-11-03) | CNY 15.49 billion | Mid-cap size |
Key valuation takeaways:
- The gap between trailing PE (40.41) and forward PE (32.89) quantifies expected near-term earnings improvement.
- P/S of 1.32 and EV/Revenue of 1.46 indicate revenue is valued reasonably relative to peers in similar sectors (neither bargain-hunt levels nor frothy premiums).
- P/B at 1.71 suggests a modest premium for intangibles or future growth; downside may be limited by book value support.
- EV/EBITDA of 15.52 places the company in a mid-range valuation for cash earnings - offering a balance between yield-seeking and growth-oriented investors.
For further context on shareholder composition and who is driving these valuation dynamics, see: Exploring Wuhu Token Sciences Co., Ltd. Investor Profile: Who's Buying and Why?
Wuhu Token Sciences Co., Ltd. (300088.SZ) - Risk Factors
- Industry concentration: Wuhu Token Sciences is heavily reliant on the touch display device materials industry, making its top-line and margins sensitive to demand cycles, product substitution and rapid technological shifts (e.g., new substrate or coating technologies).
- Debt profile: Reported debt-to-equity ratio is 33.9%, a moderate leverage level that reduces financial flexibility. Elevated leverage can increase vulnerability to rising interest rates or revenue shocks.
- Profitability pressure: Net profit margin stands at 3.44%, indicating thin margins that can be eroded by higher input costs, pricing pressure, or adverse product-mix changes.
- Geographic and regulatory exposure: Concentration in the Chinese market exposes the company to domestic regulatory changes, industry-specific policy shifts, and broader geopolitical tensions affecting trade and supply chains.
- Product concentration risk: Reliance on a limited product line tied to touch-display materials creates execution risk if customer preferences shift or competitors introduce disruptive alternatives.
- Input and supply-chain risk: Profitability and operations are sensitive to raw-material price volatility and potential supply-chain disruptions (logistics delays, supplier capacity constraints, export controls).
| Indicator | Value | Investor Implication |
|---|---|---|
| Industry concentration | Touch display device materials | High cyclicality & tech disruption risk |
| Debt-to-Equity | 33.9% | Moderate leverage; limited buffer in downturns |
| Net Profit Margin | 3.44% | Thin margins; sensitive to cost inflation |
| Geographic exposure | Primarily China | Regulatory & geopolitical sensitivity |
| Product concentration | Limited product line | Higher business-model risk |
| Supply chain | Raw-material dependent | Vulnerability to price swings and disruptions |
- Key investor watchpoints: monitor gross margin trends, working-capital movements, short-term debt maturities, supplier concentration, and any shifts in product mix or customer base.
- Triggers for elevated risk: sustained margin compression below current levels, significant increases in debt-to-equity, large customer loss, material supply disruptions, or adverse regulatory actions in China.
Wuhu Token Sciences Co., Ltd. (300088.SZ) - Growth Opportunities
Wuhu Token Sciences Co., Ltd. (300088.SZ) sits in an addressable touch-display and human-machine interaction market projected to grow at a mid-single-digit to high-single-digit CAGR over the 2024-2030 period (industry estimates commonly cite ~5-8% CAGR), creating a favorable tailwind for companies with strong R&D, vertical integration, and channel expansion strategies. The company's strategic posture suggests multiple levers to capture share and drive margin expansion.- R&D-led product differentiation: sustained investment in tactile and in-cell/on-cell touch technologies and sensor integration can translate into higher ASPs and win rates across smartphones, automotive displays, industrial HMI, and consumer electronics.
- Geographic and product-line diversification: moving beyond legacy segments into automotive displays, industrial controls, and IoT modules cushions cyclicality in consumer electronics and broadens revenue streams.
- Partnerships & OEM relationships: collaborations with panel makers, automotive Tier‑1s, and module integrators can accelerate design wins and shorten commercialization cycles.
- Automation & efficiency: factory automation and yield improvements reduce per-unit costs, improving gross margins even if average selling prices fluctuate.
- Sustainability credentials: eco-friendly materials and lower‑power display solutions appeal to OEM procurement policies and end-consumers, supporting premium positioning.
- Agility to trends: the ability to pivot toward flexible displays, haptics, and AI-driven touch interfaces will determine the company's longer-term relevance.
| Growth Vector | Near-term KPI | Mid-term Target (2-4 yrs) |
|---|---|---|
| R&D Intensity | Patents filed; new-module prototypes | Increase R&D output to support 3-5 new product launches/year |
| Market Expansion | New customer contracts; regional sales split | Double non-consumer-electronics revenue share |
| Strategic Partnerships | Number of OEM/Tier‑1 collaborations | Secure 2-3 multi-year supply agreements |
| Automation | Yield rate; labor cost % of COGS | Improve gross margin by 150-300 bps via automation |
| Sustainability | Recycled-material use; energy consumption per unit | Achieve measurable reductions in CO2 intensity and increase eco-product sales mix |
- R&D and product road map - Potential: If R&D intensity remains high, Wuhu Token Sciences is positioned to capture premium projects in automotive infotainment and industrial HMI where margins are typically higher than commodity smartphone components.
- Channel and market diversification - Potential: Expanding sales into automotive and industrial verticals can reduce revenue cyclicality tied to mobile-phone replacement cycles; commercial traction often shows multi-year purchase windows that lift visibility.
- Partnerships & ecosystem - Potential: Strategic collaborations can accelerate adoption; exclusive or preferred-supplier arrangements with panel assemblers or Tier‑1s materially increase order stability and bargaining power.
- Cost structure improvements - Potential: Capital expenditure into automation and process control can lower direct manufacturing costs and decrease defect rates, improving unit economics and allowing selective price competition.
- Sustainability & branding - Potential: Demonstrable sustainability measures and energy-efficient product certifications can unlock procurement lists of eco-conscious OEMs and governments.
- Adaptability - Potential: Rapid incorporation of emergent trends (foldable displays, in-display sensors, haptics, AI-driven touch) will be critical-firms that lag risk margin erosion from commoditization.

Wuhu Token Sciences Co., Ltd. (300088.SZ) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.